$BAYA News

Bayview Acquisition Corp Announces Favorable Nasdaq Listing Decision

Bayview Acquisition Receives Permission To Continue Listing On Nasdaq, But Most Close Business Combination With Oabay And Demonstrate Listing Rules Compliance By June 19

Bayer (0P6S) Receives a Hold from J.P. Morgan

Bayer enters licensing agreement with Dewpoint Therapeutics

J.P. Morgan Sticks to Their Hold Rating for Bayer (0P6S)

Goldman Sachs Reaffirms Their Hold Rating on Bayer (0P6S)

Deutsche Bank Keeps Their Hold Rating on Bayer (0P6S)

Bayer (0P6S) Gets a Hold from Kepler Capital

Bayer (0P6S) Receives a Hold from Jefferies

Bayer (0P6S) Gets a Hold from J.P. Morgan

J.P. Morgan Remains a Hold on Bayer (0P6S)

UBS Reaffirms Their Hold Rating on Bayer (0P6S)

DZ BANK AG Sticks to Their Buy Rating for Bayer (0P6S)

Kepler Capital Keeps Their Hold Rating on Bayer (0P6S)

UBS Remains a Hold on Bayer (0P6S)

Deutsche Bank Sticks to Its Hold Rating for Bayer (0P6S)

Jefferies Sticks to Its Hold Rating for Bayer (0P6S)

Goldman Sachs Sticks to Its Hold Rating for Bayer (0P6S)

UBS Keeps Their Hold Rating on Bayer (0P6S)

J.P. Morgan Sticks to Its Hold Rating for Bayer (0P6S)